R. Douglas Norby, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 22,000 shares at $93.00 ($2.0M) on 2012-12-10, disclosed to the SEC on 2012-12-12.
Open-market sale of $2.0M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2013-05-23 | $4.1M | — | Filing → |
| ALXN | SELL | 2012-03-12 | $2.6M | — | Filing → |
| ALXN | SELL | 2011-10-31 | $3.1M | — | Filing → |